Total Voting Rights

Summary by AI BETAClose X

Hemogenyx Pharmaceuticals plc has announced that as of November 28, 2025, its total issued share capital comprises 5,917,878 ordinary shares, with no shares held in treasury, resulting in a total of 5,917,878 voting rights. This figure will serve as the denominator for shareholders calculating their notification obligations under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules regarding their interests in the company's share capital.

Disclaimer*

UK 100

Latest directors dealings